NADMED Ltd.

NADMED Ltd. is a Finnish biotechnology company specializing in the development and commercialization of NAD (nicotinamide adenine dinucleotide) and glutathione measuring technologies. Their innovative methods offer a quick, accurate, and cost-effective way to measure all four forms of NAD and two forms of glutathione, enabling researchers and clinicians to gain deeper insights into the role of these vital metabolites in health and disease. This technology is a significant advancement from traditional methods like mass spectrometry, which are often expensive and time-consuming.

NADMED provides a range of services, including measuring kits for clinical laboratories and a comprehensive laboratory service for research and drug development. Their commitment to scientific excellence is reflected in the ongoing and completed research projects conducted in their laboratory, as well as their dedication to developing new ways to improve the accuracy, user-friendliness, and accessibility of their products.

NADMED Ltd. is a Finnish biotechnology company dedicated to revolutionizing the measurement of NAD and glutathione, vital metabolites involved in cellular energy and redox processes. They develop and market highly accurate and sensitive kits for clinical and research laboratories, enabling the measurement of all four NAD forms and two glutathiones from various sample types, including blood, tissues, and cells. By providing this comprehensive and reliable testing platform, NADMED aims to advance research into the role of NAD and glutathione in health and disease, accelerate the development of targeted treatments, and ultimately improve patient care.

NADMED promotes a collaborative and research-driven culture focused on innovation and customer satisfaction. Their emphasis on scientific excellence, combined with a commitment to developing user-friendly products and services, creates an environment where employees are encouraged to contribute to the advancement of NAD research and its application in clinical settings. The company values open communication, teamwork, and a passion for delivering high-quality solutions that improve patient care.

NADMED Ltd. is a company dedicated to advancing scientific research and clinical care related to NAD levels, a key factor in various metabolic and degenerative diseases. While there is no mention of specific diversity, equity, and inclusion initiatives on their website, NADMED's commitment to scientific innovation and collaboration suggests a focus on attracting and retaining a diverse team of researchers and professionals. Their international reach and partnerships with global laboratories further emphasize their dedication to working across boundaries and fostering a diverse scientific community.